These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Restoration of desmosomal junction protein expression and inhibition of H3K9-specific histone demethylase activity by cytostatic proline-rich polypeptide-1 leads to suppression of tumorigenic potential in human chondrosarcoma cells. Galoian K; Qureshi A; Wideroff G; Temple HT Mol Clin Oncol; 2015 Jan; 3(1):171-178. PubMed ID: 25469290 [TBL] [Abstract][Full Text] [Related]
8. Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration/invasion effects of arsenic trioxide on human chondrosarcoma. Bao X; Ren T; Huang Y; Wang S; Zhang F; Liu K; Zheng B; Guo W J Exp Clin Cancer Res; 2016 Aug; 35(1):129. PubMed ID: 27576314 [TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells as a therapeutic target in 3D tumor models of human chondrosarcoma: An encouraging future for proline rich polypeptide‑1. Granger CJ; Hoyt AK; Moran A; Becker B; Sedani A; Saigh S; Conway SA; Brown J; Galoian K Mol Med Rep; 2020 Nov; 22(5):3747-3758. PubMed ID: 32901865 [TBL] [Abstract][Full Text] [Related]
10. Antitumorigenic effect of brain proline rich polypeptide-1 in human chondrosarcoma. Galoian K; Scully S; McNamara G; Flynn P; Galoyan A Neurochem Res; 2009 Dec; 34(12):2117-21. PubMed ID: 19484491 [TBL] [Abstract][Full Text] [Related]
11. Cytostatic effect of the hypothalamic cytokine PRP-1 is mediated by mTOR and cMyc inhibition in high grade chondrosarcoma. Galoian K; Temple TH; Galoyan A Neurochem Res; 2011 May; 36(5):812-8. PubMed ID: 21243426 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-100 resensitizes resistant chondrosarcoma cells to cisplatin through direct targeting of mTOR. Zhu Z; Wang CP; Zhang YF; Nie L Asian Pac J Cancer Prev; 2014; 15(2):917-23. PubMed ID: 24568519 [TBL] [Abstract][Full Text] [Related]
13. The overexpression of miR-30a affects cell proliferation of chondrosarcoma via targeting Runx2. Jiang D; Zheng X; Shan W; Shan Y Tumour Biol; 2016 May; 37(5):5933-40. PubMed ID: 26596830 [TBL] [Abstract][Full Text] [Related]
14. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors. Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243 [TBL] [Abstract][Full Text] [Related]
15. CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells. Liu GT; Huang YL; Tzeng HE; Tsai CH; Wang SW; Tang CH Cancer Lett; 2015 Feb; 357(2):476-87. PubMed ID: 25444917 [TBL] [Abstract][Full Text] [Related]
16. Effect of cytostatic proline rich polypeptide-1 on tumor suppressors of inflammation pathway signaling in chondrosarcoma. Galoian K; Luo S; Qureshi A; Patel P; Price R; Morse AS; Chailyan G; Abrahamyan S; Temple HT Mol Clin Oncol; 2016 Nov; 5(5):618-624. PubMed ID: 27900099 [TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate suppresses chondrosarcoma metastasis by upregulation of tissue inhibitor of metalloproteinase 3 through suppressing miR-101 expression. Tsai CH; Yang DY; Lin CY; Chen TM; Tang CH; Huang YL Mol Oncol; 2017 Oct; 11(10):1380-1398. PubMed ID: 28672103 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9. Li J; Wang L; Liu Z; Zu C; Xing F; Yang P; Yang Y; Dang X; Wang K Oncotarget; 2015 Sep; 6(28):26216-29. PubMed ID: 26317788 [TBL] [Abstract][Full Text] [Related]
19. Cytostatic effect of novel mTOR inhibitor, PRP-1 (galarmin) in MDA 231 (ER-) breast carcinoma cell line. PRP-1 inhibits mesenchymal tumors. Galoian KA; Temple TH; Galoyan A Tumour Biol; 2011 Aug; 32(4):745-51. PubMed ID: 21494810 [TBL] [Abstract][Full Text] [Related]
20. Analysis of microRNAs expressions in chondrosarcoma. Yoshitaka T; Kawai A; Miyaki S; Numoto K; Kikuta K; Ozaki T; Lotz M; Asahara H J Orthop Res; 2013 Dec; 31(12):1992-8. PubMed ID: 23940002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]